PAA valued close to some Phase 3 biotechs just to provide some perspective and they have orphan drug status as well. My prediction is side ways action for awhile until Phase 2 funding is more certain and any trial catalysts.
PAA valued close to some Phase 3 biotechs just to provide some...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.010(4.55%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 24.0¢ | 20.5¢ | $364.8K | 1.685M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 230000 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 58434 | 4 |
View Market Depth
| Last trade - 15.41pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
23.0¢ |
Change
0.010 ( 3.37 %) |
||||
| Open | High | Low | Volume | ||
| 21.0¢ | 24.0¢ | 20.5¢ | 734616 | ||
| Last updated 15.58pm 01/05/2024 ? | |||||
| PAA (ASX) Chart |